The Heartbeat Trust Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2015
NCT02682719
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Heartbeat Trust, 3 Crofton Terrace, Dun Laoghaire, Co Dublin | The Heartbeat Trust

Active Ingredients

Drugs in Phase 2 Trials (2)

sacubitril (Entresto) (2 trials)

valsartan (diovan) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Remodeling (Phase 2)

Fibrosis (Phase 2)

Myositis (Phase 2)

Ventricular Dysfunction, Left (Phase 2)

Ventricular Remodeling (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2